The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study

The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study

Background: A controversy exists regarding the efficacy of programmed death-1 (PD-1)/ programmed death ligand-1 (PD-L1) inhibitors for patients with non-small cell lung cancer (NSCLC) and liver metastases. Our study retrospectively evaluated the efficacy of PD-1/PD-L1 inhibitors in NSCLC patients wi...

Full description

Bibliographic Details
Main Authors: Mingying Xie, Na Li, Xiaoling Xu, Yanjun Xu, Hui Li, Liang Zhu, Jiamin Sheng, Zichao Zhou, Yun Fan
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
liver metastasis
non-small cell lung cancer
PD-L1
PD-1/PD-L1 inhibitor
CD8+ T cell
Online Access:https://www.mdpi.com/2072-6694/14/17/4333

Internet

https://www.mdpi.com/2072-6694/14/17/4333

Similar Items